| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yanlin Lang, William Robert Kwapong, Lingyao Kong, Ziyan Shi, Xiaofei Wang, Qin Du, Bo Wu, Hongyu Zho. Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study. Frontiers in immunology. vol 14. 2023-02-16. PMID:36793713. |
retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: an oct/octa study. |
2023-02-16 |
2023-08-14 |
Not clear |
| Yanlin Lang, William Robert Kwapong, Lingyao Kong, Ziyan Shi, Xiaofei Wang, Qin Du, Bo Wu, Hongyu Zho. Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study. Frontiers in immunology. vol 14. 2023-02-16. PMID:36793713. |
to compare the optical coherence tomography (oct)/oct angiography (octa) measures in patients with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad). |
2023-02-16 |
2023-08-14 |
Not clear |
| M Etemadifar, M Fereidan-Esfahani, N Sedaghat, P K Kargaran, A R Mansouri, A P Abhari, A Aghababaei, A Jannesari, M Salari, M Ganjalikhani-Hakemi, H Nour. Non-infectious meningitis and CNS demyelinating diseases: A conceptual review. Revue neurologique. 2023-02-13. PMID:36781321. |
we gathered and tabulated cases of non-infectious, steroid-responsive meningitis or meningoencephalitis associated with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein-associated disease (mogad). |
2023-02-13 |
2023-08-14 |
Not clear |
| Sohyeon Kim, Hung Youl Seo. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-02-13. PMID:36781562. |
vaccination against the coronavirus disease 2019 (covid-19) is recommended for patients with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2023-02-13 |
2023-08-14 |
Not clear |
| Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palac. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet. Neurology. 2023-01-27. PMID:36706773. |
serum antibodies directed against myelin oligodendrocyte glycoprotein (mog) are found in patients with acquired cns demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder. |
2023-01-27 |
2023-08-14 |
Not clear |
| Martin W Hümmert, Franziska Bütow, Daria Tkachenko, Ilya Ayzenberg, Thivya Pakeerathan, Kerstin Hellwig, Luisa Klotz, Vivien Häußler, Jan-Patrick Stellmann, Clemens Warnke, Yasemin Goereci, Thorleif Etgen, Felix Luessi, Paul Bronzlik, Stefan Gingele, Ann-Sophie Lauenstein, Ingo Kleiter, Paulus S Rommer, Friedemann Paul, Judith Bellmann-Strobl, Ankelien Duchow, Florian Then Bergh, Refik Pul, Annette Walter, Hannah Pellkofer, Tania Kümpfel, Mosche Pompsch, Markus Kraemer, Philipp Albrecht, Orhan Aktas, Marius Ringelstein, Makbule Senel, Katrin Giglhuber, Achim Berthele, Sven Jarius, Brigitte Wildemann, Corinna Trebs. Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 2. 2023-01-24. PMID:36693760. |
to evaluate the effects of the coronavirus disease 2019 (covid-19) pandemic on the life of patients with neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated diseases (mogad). |
2023-01-24 |
2023-08-14 |
Not clear |
| Anna A Shah, Andrew B Wolf, Anthony Declusin, Kyle Coleman, Ryan Kammeyer, Baber Khan, John R Corbo. Challenging Cases in Neuroimmunology. Seminars in neurology. vol 42. issue 6. 2023-01-23. PMID:36690027. |
by highlighting these challenging cases, we hope to instill fundamental points on the nuances of diagnosis and management for conditions including tumefactive multiple sclerosis, antibody-mediated encephalitis, antiphospholipid antibody syndrome, neuromyelitis optica, and myelin oligodendrocyte glycoprotein igg-associated disease. |
2023-01-23 |
2023-08-14 |
Not clear |
| Mercedeh Farhat Sabet, Sumanta Barman, Mathias Beller, Sven G Meuth, Nico Melzer, Orhan Aktas, Norbert Goebels, Tim Prozorovsk. Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity. International journal of molecular sciences. vol 24. issue 1. 2023-01-08. PMID:36613687. |
anti-nmda receptor (nmdar) encephalitis is frequently associated with demyelinating disorders (e.g., multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein-associated disease (mogad)) with regard to clinical presentation, neuropathological and cerebrospinal fluid findings. |
2023-01-08 |
2023-08-14 |
Not clear |
| Jorge Guzmán, Francisco Vera, Bernardita Soler, Reinaldo Uribe-San-Martin, Lorena García, Adolfo Del-Canto, Andrea Schlatter, Mauricio Salazar, Fernando Molt, Karla Ramirez, José Marín, Carolina Pelayo, Juan Pablo Cruz, Sebastián Bravo-Grau, Claudia Cárcamo, Ethel Ciamp. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases. Multiple sclerosis and related disorders. vol 69. 2022-12-15. PMID:36521387. |
anti-myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad) is an emerging disorder recognized as a clinical entity distinct from multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorders (nmosd-aqp4+), and its phenotypic spectrum continues to expand. |
2022-12-15 |
2023-08-14 |
Not clear |
| Itay Lotan, Thibo Billiet, Annemie Ribbens, Wim Van Hecke, Benny Huang, Ilya Kister, Eyal Lota. Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis. Multiple sclerosis and related disorders. vol 69. 2022-12-13. PMID:36512956. |
relatively little is known about how global and regional brain volumes changes in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) compare with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and healthy controls (hc). |
2022-12-13 |
2023-08-14 |
Not clear |
| Hadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, Alon Tiosano, Itay Lotan, Mark A Hellmann, Adi Wilf-Yarkoni, Omer Bialer, Eoin P Flanagan, Sean J Pittock, M Tariq Bhatti, Tanja Schmitz-Hübsch, Paul Friedemann, Susanna Asseyer, John J Che. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Scientific reports. vol 12. issue 1. 2022-12-09. PMID:36494385. |
optic neuritis (on) is a frequent presentation at onset of multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2022-12-09 |
2023-08-14 |
Not clear |
| Angelika Bauer, Dagmar Rudzki, Klaus Berek, Alessandro Dinoto, Christian Lechner, Eva-Maria Wendel, Harald Hegen, Florian Deisenhammer, Thomas Berger, Romana Höftberger, Kevin Rostasy, Sara Mariotto, Markus Reind. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Frontiers in immunology. vol 13. 2022-12-01. PMID:36451827. |
increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. |
2022-12-01 |
2023-08-14 |
Not clear |
| Angelika Bauer, Dagmar Rudzki, Klaus Berek, Alessandro Dinoto, Christian Lechner, Eva-Maria Wendel, Harald Hegen, Florian Deisenhammer, Thomas Berger, Romana Höftberger, Kevin Rostasy, Sara Mariotto, Markus Reind. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Frontiers in immunology. vol 13. 2022-12-01. PMID:36451827. |
autoantibody-associated demyelinating diseases of the central nervous system such as myelin oligodendrocyte glycoprotein-antibody associated disease (mogad) and aquaporin 4-antibody positive neuromyelitis optica spectrum disorders (aqp4+ nmosd) are rare diseases but can cause severe disability. |
2022-12-01 |
2023-08-14 |
Not clear |
| Jamie Jacobs, Priscilla Vu, Antonio K Li. A Patient With Myelin Oligodendrocyte Glycoprotein Positive Encephalitis With Ring Enhancing Lesions on Magnetic Resonance Imaging (MRI) After COVID-19 Exposure. Cureus. vol 14. issue 11. 2022-11-30. PMID:36447808. |
myelin oligodendrocyte glycoprotein (mog) antibody has been associated with a wide range of neurological diseases, from neuromyelitis optica spectrum disorder to acute disseminated encephalomyelitis. |
2022-11-30 |
2023-08-14 |
Not clear |
| Giulia Fadda, Eoin P Flanagan, Laura Cacciaguerra, Jiraporn Jitprapaikulsan, Paolo Solla, Pietro Zara, Elia Sech. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. Frontiers in neurology. vol 13. 2022-11-24. PMID:36419536. |
three main demyelinating disorders of the central nervous system, namely multiple sclerosis (ms), aquaporin-4-igg-positive neuromyelitis optica spectrum disorders (aqp4+nmosd) and myelin oligodendrocyte glycoprotein-igg associated disease (mogad), can induce spinal cord inflammation through different pathogenic mechanisms, resulting in a more or less profound disruption of spinal cord integrity. |
2022-11-24 |
2023-08-14 |
Not clear |
| Magdalena Lerch, Kathrin Schanda, Eliott Lafon, Reinhard Würzner, Sara Mariotto, Alessandro Dinoto, Eva Maria Wendel, Christian Lechner, Harald Hegen, Kevin Rostásy, Thomas Berger, Doris Wilflingseder, Romana Höftberger, Markus Reind. More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 1. 2022-11-22. PMID:36414427. |
the objective was to study complement-mediated cytotoxicity induced by immunoglobulin g (igg) anti-aquaporin-4 antibodies (aqp4-igg) and anti-myelin oligodendrocyte glycoprotein antibodies (mog-igg) in human serum samples from patients suffering from the rare demyelinating diseases of the cns neuromyelitis optica spectrum disorder (nmosd) and mog-igg-associated disease (mogad). |
2022-11-22 |
2023-08-14 |
human |
| Dimitrios C Ladakis, Jennifer Gould, Jenny M Khazen, Julia M Lefelar, Scott Tarpey, Charles J Bies, Rebecca Salky, Kathryn C Fitzgerald, Pavan Bhargava, Bardia Nourbakhsh, Elias S Sotircho. Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease. Multiple sclerosis journal - experimental, translational and clinical. vol 8. issue 4. 2022-11-21. PMID:36407471. |
unlike multiple sclerosis and neuromyelitis optica, the burden of fatigue in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is unclear. |
2022-11-21 |
2023-08-14 |
Not clear |
| Darius Mewes, Joseph Kuchling, Patrick Schindler, Ahmed Abdelrahim Ahmed Khalil, Sven Jarius, Friedemann Paul, Claudia Chie. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD). Klinische Monatsblatter fur Augenheilkunde. vol 239. issue 11. 2022-11-21. PMID:36410333. |
aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad; also termed mog encephalomyelitis) are autoimmune diseases of the central nervous system. |
2022-11-21 |
2023-08-14 |
Not clear |
| Anna G Francis, Kariem Elhadd, Valentina Camera, Monica Ferreira Dos Santos, Chiara Rocchi, Poneh Adib-Samii, Bal Athwal, Kathrine Attfield, Andrew Barritt, Matthew Craner, Leonora Fisniku, Astrid K N Iversen, Oliver Leach, Lucy Matthews, Ian Redmond, Jonathan O'Riordan, Antonio Scalfari, Radu Tanasescu, Damian Wren, Saif Huda, Maria Isabel Leite, Lars Fugger, Jacqueline Palac. Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 1. 2022-11-21. PMID:36411077. |
acute inflammatory cns diseases include neuromyelitis optica spectrum disorders (nmosds) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2022-11-21 |
2023-08-14 |
Not clear |
| Abhay Ranjan, Sanaullah Mudassir, Neetu Sinha, Ankit Panjwani, Ashok Kuma. Area Postrema Syndrome: An Initial Presentation of Double-Seropositive AQP4 and MOG Antibodies. Neurology. Clinical practice. vol 12. issue 4. 2022-11-16. PMID:36382120. |
aps is mostly associated with neuromyelitis optica (nmo) and rarely reported in myelin oligodendrocyte glycoprotein antibody disease. |
2022-11-16 |
2023-08-14 |
Not clear |